Metabolic Syndrome and COVID 19: Endocrine-Immune-Vascular Interactions Shapes Clinical Course

The ongoing coronavirus disease 2019 (COVID-19) pandemic is caused by the novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Individuals with metabolic syndrome are at increased risk for poor disease outcomes and mortality from COVID-19. The pathophysiologic mechanisms...

Descripción completa

Detalles Bibliográficos
Autores principales: Bansal, Rashika, Gubbi, Sriram, Muniyappa, Ranganath
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Mini-Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337756/
https://www.ncbi.nlm.nih.gov/pubmed/32603424
http://dx.doi.org/10.1210/endocr/bqaa112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337756/
https://www.ncbi.nlm.nih.gov/pubmed/32603424
http://dx.doi.org/10.1210/endocr/bqaa112

Ejemplares similares